| Client: | Mid-sized, Japanese pharmaceutical company with little experience outside Japan |
| Challenge: | Create a clinical development plan for a product that accelerates fracture healing. The client needed a plan that would satisfy global regulatory authorities and enable it to market the product with affiliates in Europe and the US. |
| Outcome: | A PharmaNet team with experience in pre-clinical and clinical development planning in both Europe and US assessed the product and its clinical environment, produced a clinical development plan, and delivered an estimated protocol synopses for the phase II and III pivotal studies. With PharmaNet's assistance, the client produced a credible plan to bring the product to market in Europe and the US, obtained FDA approval of its plan, and is now proceeding with trials. |













504 Carnegie Center, Princeton, NJ 08540